Updated August 2026 with new evidence, including a 46 study meta-analysis published in June 2026 and a 24 week randomized controlled trial.

The aging muscle story is more complicated and more hopeful than you have been told.

In June 2026, Kristiansen and colleagues published a systematic review and meta-analysis in Frontiers in Physiology pooling 46 stable isotope tracer studies that compared muscle protein synthesis (MPS) in young and older adults. The most revealing number in the paper is not an effect size. It is this: only 15 of those 46 studies described how physically active their participants were, and only 3 actually measured it.

That is the anabolic resistance literature summarized in one statistic. For two decades the field has attributed to aging a difference it almost never controlled for. When you look at what the pooled data actually show, the picture is smaller, more specific, and far more useful than the version that gets repeated in supplement marketing.

How the idea got started

Katsanos et al. (2005) established the concept in the American Journal of Clinical Nutrition. Elderly subjects showed significantly less muscle protein accretion than young subjects after ingesting a small 6.7g bolus of essential amino acids (EAAs). The muscle appeared resistant to the anabolic signal.

The obvious fix was more. Paddon-Jones et al. (2004) had already shown that at a 15g EAA dose, young and elderly subjects raised MPS by roughly the same amount, about 0.04%/h. Out of those two studies came the recommendation that has dominated aging nutrition advice ever since: older adults simply need a bigger dose.

Then Shad et al. (2016), reviewing the evidence in the American Journal of Physiology: Endocrinology and Metabolism, argued that much of what gets blamed on anabolic resistance actually reflects reduced physical activity, chronic low-grade inflammation, and suboptimal protein intake. Ten years on, that argument has aged considerably better than the dose story.

How big the effect really is, and where it disappears

What makes the 2026 meta-analysis useful is that it separated MPS measurements by condition. In the post-absorptive (fasted) state, older adults showed a modest deficit (SMD -0.167, p=0.025). After feeding, the gap was somewhat larger but still modest (SMD -0.348, p=0.014). These are real differences. They are not the collapse in responsiveness that the word "resistance" implies.

Then the pattern breaks. After exercise, the age difference largely vanished. Five of eight studies found no difference between young and older adults. When feeding and exercise were combined, seven of nine studies found no age difference at all.

And the variable most people assume is the answer turned out not to be. The analysis found no significant association between protein dose and the size of the age related MPS difference. The authors concluded that older muscle retains its anabolic potential when it is given the right stimuli. Exercise, not dose, is the lever.

A direct experiment points the same way. Moro et al. (2018) at the University of Texas Medical Branch put 19 healthy older adults, mean age 71, through 12 weeks of progressive resistance training, and measured the muscle protein synthesis response to 6.8g of essential amino acids before and after the program. The training clearly worked: strength rose 16%, muscle cross sectional area 27%, and basal muscle protein synthesis 36%. The response to the amino acids was already intact at baseline, and training did not change it. A small EAA dose was sufficient in untrained older muscle, which is not what an anabolic resistance model predicts. The authors concluded that anabolic resistance to amino acids may not be a problem in healthy older adults at all.

Why "just eat more protein" is not the whole answer

A trial from the van Loon group at Maastricht, published online ahead of print in the Journal of Nutrition in August 2026, tested the dose and quality assumption head on. Kuin and colleagues randomized 45 healthy older males (mean age 69) to one of three drinks: 20g of a soy and pea protein blend, the same blend fortified with 2g of free leucine, or 20g of whey. Using primed continuous tracer infusion with blood and muscle sampling out to four hours, they measured post-prandial MPS at 0.034, 0.035, and 0.034 %/h respectively. No difference between treatments. And none of the three raised MPS above post-absorptive rates at all. Whey delivered the largest rise in plasma essential amino acids of the three drinks, and it changed nothing. Their conclusion was blunt: 20g of protein, independent of quality, is not enough to increase MPS in older males at rest.

This deserves a careful reading rather than an alarmed one. 20g of whey delivers roughly 10g of EAAs and about 2.2g of leucine, which is not the same thing as an equivalent dose of free EAAs absorbed without the non-essential ballast. The trial does not establish what a larger free EAA dose would have done. What it does do is undercut the tidy idea that you can dose your way past anabolic resistance while sitting still, and it does so at a serving size millions of older adults are actually consuming.

What supplementation plus training actually delivers

The most informative long-term trial here is Markofski et al. (2019), published in the Journals of Gerontology Series A and funded by the NIH. It ran 24 weeks with a 2x2 factorial design: 15g of EAAs daily (a 40% leucine mixture) or placebo, crossed with supervised aerobic exercise or habitual activity. Participants were healthy, nonfrail, low-active older adults with a mean age of 72, and 45 completed the study.

The results were specific. Muscle strength improved only in the group that received both EAAs and exercise. So did muscle quality, meaning strength per unit of lean mass. EAA ingestion acutely raised MPS both before and after the intervention, and the response was larger at 24 weeks, which suggests the muscle became more sensitive over time rather than less.

Lean body mass did not change in any group. Not with EAAs, not with exercise, not with both. And the exercise was walking, not resistance training.

A 2026 systematic review and meta-analysis in BMC Musculoskeletal Disorders by Xie and colleagues arrived at the same destination from a different direction. Pooling nine randomized trials and 496 older adults with sarcopenia (mean age 78.3) doing resistance training with or without amino acid based supplementation, the combined groups showed significantly better handgrip strength (SMD 0.69), gait speed (SMD 0.64), five times sit-to-stand performance (SMD -1.42), and Short Physical Performance Battery scores (SMD 1.69). Skeletal muscle mass index and appendicular skeletal muscle mass showed no significant benefit. The authors graded that evidence low to very low certainty, with heterogeneity running from 78 to 92%, so read the effect sizes as directional rather than precise.

Two independent lines of evidence, one aerobic and one resistance based, land in the same place. Function improves. Mass does not. That is not a disappointing result. Strength and gait speed, not muscle mass, are what predict mobility limitation and mortality in older cohorts. For a 75 year old, rising from a chair unassisted matters more than a number on a body composition scan.

One further finding from Markofski belongs here because it cuts against convenient storytelling. Fat mass tended to increase in the EAA-only group and decreased in the group that exercised on placebo. The authors speculated that EAA supplementation in older adults already eating adequate protein may promote lipogenesis unless it is paired with exercise. That is one more reason the pairing matters.

Markofski also reported that the acute MPS changes did not predict the long-term treatment effects over 24 weeks. That is worth sitting with, because most of what the supplement industry cites about EAAs and aging comes from acute studies exactly like the ones quoted above. A four hour tracer measurement tells you something real about mechanism. It does not reliably tell you what happens over six months.

The leucine question is genuinely open

The standard claim is that older adults need a higher leucine threshold to trigger MPS. The evidence is more divided than that framing allows.

Against a simple threshold story: Glynn et al. (2010) found that inside a fixed 10g EAA dose, 3.5g of leucine outperformed 1.8g on anabolic signaling but produced no improvement in MPS or net protein balance, though that study was in young adults. In the Kuin trial above, the leucine-fortified arm reached the highest peak plasma leucine of the three conditions, 567 µmol/L versus 471 for whey and 310 for the unfortified blend, and still produced nothing. And a 2026 double-blind randomized trial in the American Journal of Clinical Nutrition found that leucine supplementation failed to slow the decline in MPS or preserve muscle mass during short-term leg immobilization in either young or older adults.

For leucine still mattering: Zaromskyte et al. (2021) systematically reviewed 29 studies testing the leucine trigger hypothesis and found 16 supported it. Of those 16, thirteen were conducted in older adults, and eight of those measured MPS after exercise. Whatever predictive power blood leucine has, it appears concentrated in exactly the population and the context this article is about. In the Xie meta-analysis, leucine based supplements produced the largest handgrip effect of any subgroup (SMD 1.84).

Worth restating from the Moro trial above: the 6.8g EAA mixture used there carries 1.77g of leucine, and it drove a normal response in older adults both before and after training. Whatever the real threshold is, there is no good evidence it sits above what a standard EAA serving already delivers.

The honest position is that leucine content alone is a poor predictor of the MPS response, that signaling and synthesis can dissociate, and that what older adults need around exercise is still an open question.

What to do about it

There is no established older-adult-specific EAA dose, and the newest evidence argues against the premise that one exists. Any brand telling you otherwise is selling ahead of the data, and that includes anyone quoting a tidy number without a trial behind it.

What the evidence does support is simpler and harder. Move. The most consistent finding across the 2026 meta-analysis, the Markofski trial, and the Xie review is that the anabolic response in older muscle is largely intact when exercise is part of the picture and unreliable when it is not. Walking was enough in Markofski. Resistance training was the backbone in Xie. Take protein and EAAs around training rather than in isolation, because that is the condition under which the age difference disappears. Then judge the result by what you can do, not by what a scan says.

The bottom line

Anabolic resistance is real, modest, and mostly confined to the rested and fed states. It largely disappears when exercise is involved, and protein dose does not explain the age gap. The measurable payoff from EAA supplementation in older adults shows up in strength, walking speed, and physical function rather than in muscle mass. The story was never "take more." It is "pair it with training."

References

1. Kristiansen JB, Vissing K, Nielsen JL. Age-related anabolic resistance and post-absorptive muscle protein synthesis: integrative evidence from a systematic review and meta-analysis. Front Physiol. 2026;17:1740284. Frontiers
2. Katsanos CS, Kobayashi H, Sheffield-Moore M, et al. Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr. 2005;82(5):1065-1073. PubMed
3. Paddon-Jones D, Sheffield-Moore M, Zhang XJ, et al. Amino acid ingestion improves muscle protein synthesis in the young and elderly. Am J Physiol Endocrinol Metab. 2004;286(3):E321-E328. PubMed
4. Shad BJ, Thompson JL, Breen L. Does the muscle protein synthetic response to exercise and amino acid-based nutrition diminish with advancing age? A systematic review. Am J Physiol Endocrinol Metab. 2016;311(5):E803-E817. PubMed
5. Kuin LME, Hermans WJH, Boot N, et al. Ingestion of 20 g of a plant-derived protein blend with and without added leucine or whey protein does not increase muscle protein synthesis rates in older males. J Nutr. 2026 Aug 17:101789. Online ahead of print. PubMed
6. Markofski MM, Jennings K, Timmerman KL, et al. Effect of aerobic exercise training and essential amino acid supplementation for 24 weeks on physical function, body composition, and muscle metabolism in healthy, independent older adults: a randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2019;74(10):1598-1604. DOI
7. Xie C, Yan R, Tao R. Combined resistance training and amino acid-based supplementation for sarcopenia in older adults: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2026;27(1):35. Springer
8. Glynn EL, Fry CS, Drummond MJ, et al. Excess leucine intake enhances muscle anabolic signaling but not net protein anabolism in young men and women. J Nutr. 2010;140(11):1970-1976. DOI
9. Leucine supplementation does not attenuate the decline in daily muscle protein synthesis rates or preserve leg muscle mass during leg immobilization in young or older adults: a double-blind randomized trial. Am J Clin Nutr. 2026. PubMed
10. Zaromskyte G, Prokopidis K, Ioannidis T, Tipton KD, Witard OC. Evaluating the leucine trigger hypothesis to explain the post-prandial regulation of muscle protein synthesis in young and older adults: a systematic review. Front Nutr. 2021;8:685165. PubMed
11. Moro T, Brightwell CR, Deer RR, Graber TG, Galvan E, Fry CS, Volpi E, Rasmussen BB. Muscle protein anabolic resistance to essential amino acids does not occur in healthy older adults before or after resistance exercise training. *J Nutr.* 2018;148(6):900-909. PubMed